Novartis sells stake in joint venture to GSK for $13 bn

Swiss pharmaceuticals giant Novartis announced Tuesday it will sell its stake its in its consumer healthcare joint venture to Britain’s GlaxoSmithKline for $13 billion (10.4 billion euros). The group said the sale of the 36.5 percent stake will enable it “to further focus on the development and growth of its core businesses.” It said the completion…



rawpixel / Pixabay

LEAVE A COMMENT


Saved Articles
X
TextTExtLInkTextTExtLInk

Are you a smart investor? Join tens of thousands of sophisticated investor reading our authoritative free newsletter

* indicates required


Congrats! Are you a smart person?

We have an exclusive targeted for being a sophisticated and loyal reader.

Sign up for ValueWalkPremium today and get our exclusive content for 35% off.

Use coupon code vip19 or click on the button below

Limited time offer only ENDS 11/30/2019 or after next 25 13 subscribers take advantage whichever comes first – please do not share this discount with others

 

0